Immunotherapy Genetics 101

Internet Search Results

Immunotherapy for Cancer - NCI
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Learn about the types of immunotherapy and what you can expect during treatment.

Side Effects of Immunotherapy - NCI - National Cancer Institute
Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body. Learn about the types of side effects that immunotherapy might cause and where to go for more information.

Definition of immunotherapy - NCI Dictionary of Cancer Terms
Immunotherapy uses the body’s immune system to fight cancer. This animation explains three types of immunotherapy used to treat cancer: nonspecific immune stimulation, T-cell transfer therapy, and immune checkpoint inhibitors.

Immune Checkpoint Inhibitors - NCI - National Cancer Institute
Immune checkpoint inhibitors are a type of immunotherapy that block immune checkpoint proteins from binding with partner proteins. Learn about the cancers treated with checkpoint inhibitors and the side effects they may cause.

AI Tool May Help Guide Use of Cancer Immunotherapy - NCI
Is Immunotherapy the Only Cancer Treatment Some People Need? In small clinical trials, a few months of immunotherapy alone eliminated some patients' tumors.

Pembrolizumab improves outcomes in high-risk bladder cancer
Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder.

Immunotherapy: How the Immune System Fights Cancer - NCI
Immunotherapy uses the body’s immune system to fight cancer. This animation explains three types of immunotherapy used to treat cancer: nonspecific immune stimulation, T-cell transfer therapy, and immune checkpoint inhibitors.

Empowering Immune Systems | Center for Cancer Research
A personalized approach to cellular immunotherapy helps shrink solid tumors. A new approach to cellular immunotherapy, outlined here, holds promise for patients with solid epithelial cancers. The treatment is highly personalized.

T-cell Transfer Therapy - Immunotherapy - NCI
How does T-cell transfer therapy work against cancer? T-cell transfer therapy is a type of immunotherapy that makes your own immune cells better able to attack cancer. There are two main types of T-cell transfer therapy: tumor-infiltrating lymphocytes (or TIL) therapy and CAR T-cell therapy.

Imfinzi, Keytruda Approved for Some Endometrial Cancers
FDA has approved three new immunotherapy options, including pembrolizumab (Keytruda) and durvalumab (Imfinzi), with chemo for advanced endometrial cancer.

* Latest Genetics 101 News *

*** News Filter: "Immunotherapy"

Candel snags $130M loan to carry immunotherapy over the regulatory finish line  FirstWord Pharma
Funding cuts threaten new generation of cancer immunotherapies, researcher says  statnews.com
Dendritic cell progenitors engineered to express extracellular-vesicle–internalizing receptors enhance cancer immunotherapy in mouse models  Nature
HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer  Yahoo Finance
Immunotherapy Could Enable Periods of Drug-Free HIV Suppression  Technology Networks
Onc Nurse On Call: Immunotherapy With Kristin Daly  Oncology Nursing News
Pilatus Biosciences Announces Issuance of Foundational Global Patent Covering Novel CD36-Targeted Immunotherapy  BioSpace
Biomarker Analysis Reveals Clues to Long-Term Survival in Glioblastoma Patients Treated with SurVaxM | Newswise  Newswise
Immunotherapy Developer Expands Beyond Myeloid Cells and Cancer  Genetic Engineering and Biotechnology News
Scientists just cracked the mystery of why cancer immunotherapy fails  Science Daily
Turning cold tumors into hot tumors to ignite immunotherapy  Molecular Cancer
HCW Biologics Inc. to Present Innovative Immunotherapy Research at the 40th Annual Meeting of the Society for Immunotherapy of Cancer  Quiver Quantitative
The Future of Immunotherapy Research at MSK: A Conversation With Dr. Andy Minn, Chair of MSK’s New Immuno-Oncology Program  Memorial Sloan Kettering Cancer Center
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer  Nature
T-cell Immunotherapy Market Size to Hit USD 26.53 Billion by 2034  Precedence Research